Increased autoimmune activity against 5-HT: A key component of depression that is associated with inflammation and activation of cell-mediated immunity, and with severity and staging of depression

Journal of Affective Disorders

Volumn 136, Issue 3, 2012, Pages 386-392

  Maes, Michael ^a   Ringel, Karl ^b   Kubera, Marta ^c   Berk, Michael ^d   Rybakowski, Janusz ^e  

^a Piyavate Hospital   (Thailand)

^b Immunologischen Laboratorien   (Germany)

^c INSTITUTE OF PHARMACOLOGY   (Poland)

^d DEAKIN UNIVERSITY   (Australia)

^e Department of Psychiatry ^*  (Poland)

Author keywords

Autoimmunity; Cytokines; Depression; Fatigue and somatic symptoms; Inflammation; Serotonin

Indexed keywords

INTERLEUKIN 1; LYSOZYME; NEOPTERIN; SEROTONIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CELLULAR IMMUNITY; CHRONIC FATIGUE SYNDROME; CONTROLLED STUDY; DEPRESSION; DISEASE SEVERITY; FEMALE; FIBROMYALGIA; FIBROMYALGIA AND CHRONIC FATIGUE SYNDROME RATING SCALE; HAMILTON SCALE; HUMAN; IMMUNOREACTIVITY; INCIDENCE; INFLAMMATION; MAJOR CLINICAL STUDY; MALAISE; MALE; MELANCHOLIA; PRIORITY JOURNAL; RATING SCALE;

ADULT; AUTOIMMUNITY; DEPRESSIVE DISORDER; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; IMMUNITY, CELLULAR; INFLAMMATION; INTERLEUKIN-1; MALE; MIDDLE AGED; MURAMIDASE; NEOPTERIN; SEROTONIN; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84857361203     PISSN: 01650327     EISSN: 15732517     Source Type: Journal    
DOI: 10.1016/j.jad.2011.11.016     Document Type: Article

References (69)

1. I. Allaman, H. Fiumelli, P.J. Magistretti, and J.L. Martin Fluoxetine regulates the expression of neurotrophic/growth factors and glucose metabolism in astrocytes Psychopharmacology 216 1 2011 75 84
2. A. Amara, C. Chaugier, J.M. Ragnaud, and M. Geffard Circulating autoantibodies directed against conjugated fatty acids in sera of HIV-1-infected patients Clinical and Experimental Immunology 96 3 1994 379 383
3. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders, 4th ed. Text Revision (DSM-IV-TR) 2000 American Psychiatric Press Washington DC
4. M. Berk, P. Conus, N. Lucas, K. Hallam, G.S. Malhi, S. Dodd, L.N. Yatham, A. Yung, and P. McGorry Setting the stage: from prodrome to treatment resistance in bipolar disorder Bipolar Disorders 9 7 2007 671 678
5. M. Berk, F. Kapczinski, A.C. Andreazza, O.M. Dean, F. Giorlando, M. Maes, M. Yücel, C.S. Gama, S. Dodd, B. Dean, P.V. Magalhães, P. Amminger, P. McGorry, and G.S. Malhi Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors Neuroscience and Biobehavioral Reviews 35 3 2011 804 817
6. D. Bodet, G. Glaize, M.P. Dabadie, and M. Geffard Immunological follow-up for multiple sclerosis Immuno-Analyse & Biologie Specialisee 19 2004 138 147
7. Y. Chen, T. Jiang, P. Chen, J. Ouyang, G. Xu, Z. Zeng, and Y. Sun Emerging tendency towards autoimmune process in major depressive patients: a novel insight from Th17 cells Psychiatry Research 188 2 2011 224 230
8. R. Deberdt, J. Van Hooren, M. Biesbrouck, and W. Amery Antinuclear factor-positive mental depression: a single disease entity? Biological Psychiatry 11 1 1976 69 74
9. R.L. Djavadian Serotonin and neurogenesis in the hippocampal dentate gyrus of adult mammals Acta Neurobiologiae Experimentalis 64 2 2004 189 200
10. E. Engvall Enzyme immunoassay ELISA and EMIT Methods in Enzymology 70(A) 1980 419 439
11. M. Gastpar, and W. Müller Auto-antibodies in affective disorders Progress in Neuro-Psychopharmacology 5 1 1981 91 97
12. C.M. Geffard, D. Bodet, Y. Martinet, and M.-P. Dabadie Detection of the specific IgM and IgA circulating in sera of multiple sclerosis patients: interest and perspectives Immuno-Analyse & Biologie Specialisee 17 2002 302 310
13. M. Geffard, D. Bodet, M.P. Dabadie, and L. Arnould Identification of antibodies in sera of breast cancer patients Immuno-Analyse & Biologie Specialisee 18 2003 248 253
14. A.D. Haddad, J.M. Williams, S.F. McTavish, and C.J. Harmer Low-dose tryptophan depletion in recovered depressed women induces impairments in autobiographical memory specificity Psychopharmacology 207 3 2009 499 508
15. M. Hamilton A rating scale for depression Journal of Neurology, Neurosurgery, and Psychiatry 23 1960 56 62
16. J. Hannestad, N. Dellagioia, and M. Bloch The effect of antidepressant medication treatment on serum levels of inflammatory cytokines: a meta-analysis Neuropsychopharmacology 36 12 2011 2452 2459
17. S. Hasegawa, K. Nishi, A. Watanabe, D.H. Overstreet, and M. Diksic Brain 5-HT synthesis in the Flinders Sensitive Line rat model of depression: an autoradiographic study Neurochemistry International 48 5 2006 358 366
18. H. Horikawa, T.A. Kato, Y. Mizoguchi, A. Monji, Y. Seki, T. Ohkuri, L. Gotoh, M. Yonaha, T. Ueda, S. Hashioka, and S. Kanba Inhibitory effects of SSRIs on IFN-γ? Induced microglial activation through the regulation of intracellular calcium Progress in Neuro-Psychopharmacology & Biological Psychiatry 34 7 2010 1306 1316
19. G. Huether, and P. Schuff-Werner Platelet serotonin acts as a locally releasable antioxidant Advances in Experimental Medicine and Biology 398 1996 299 306
20. Y. Jiang, R. Deacon, D.C. Anthony, and S.J. Campbell Inhibition of peripheral TNF can block the malaise associated with CNS inflammatory diseases Neurobiology of Disease 32 1 2008 125 132
21. F. Kapczinski, V.V. Dias, M. Kauer-Sant'Anna, E. Brietzke, G.H. Vázquez, E. Vieta, and M. Berk The potential use of biomarkers as an adjunctive tool for staging bipolar disorder Progress in Neuro- Psychopharmacology & Biological Psychiatry 33 8 2009 1366 1371
22. T. Katafuchi, T. Kondo, S. Take, and M. Yoshimura Brain cytokines and the 5-HT system during poly I:C-induced fatigue Annals of the New York Academy of Sciences 1088 2006 230 237
23. M. Kauer-Sant'Anna, F. Kapczinski, A.C. Andreazza, D.J. Bond, R.W. Lam, L.T. Young, and L.N. Yatham Brain-derived neurotrophic factor and inflammatory markers in patients with early- vs. late-stage bipolar disorder The International Journal of Neuropsychopharmacology 12 4 2009 447 458
24. R. Klein, C. Richter, and P.A. Berg Antibodies against central nervous system tissue (anti-CNS) detected by ELISA and Western blotting: marker antibodies for neuropsychiatric manifestations in connective tissue diseases Autoimmunity 10 1991 133 144
25. B. Kronenberger, M. Wagner, E. Herrmann, U. Mihm, A. Piiper, C. Sarrazin, and S. Zeuzem Apoptotic cytokeratin 18 neoepitopes in serum of patients with chronic hepatitis C Journal of Viral Hepatitis 12 3 2005 307 314
26. M. Kubera, G. Kenis, E. Bosmans, S. Scharpé, and M. Maes Effects of serotonin and serotonergic agonists and antagonists on the production of interferon-gamma and interleukin-10 Neuropsychopharmacology 23 1 2000 89 98
27. M. Kubera, M. Maes, G. Kenis, Y.K. Kim, and W. Lasońn Effects of serotonin and serotonergic agonists and antagonists on the production of tumor necrosis factor alpha and interleukin-6 Psychiatry Research 134 3 2005 251 258
28. M. Kubera, E. Obuchowicz, L. Goehler, J. Brzeszcz, and M. Maes In animal models, psychosocial stress-induced (neuro)inflammation, apoptosis and reduced neurogenesis are associated to the onset of depression Progress in Neuro-Psychopharmacology & Biological Psychiatry 35 3 2011 744 759
29. B.E. Leonard, and C. Song Changes in the immune system in rodent models of depression The International Journal of Neuropsychopharmacology 5 4 2002 345 356
30. M. Maes Evidence for an immune response in major depression: a review and hypothesis Progress in Neuro-Psychopharmacology & Biological Psychiatry 19 1 1995 11 38
31. M. Maes The cytokine hypothesis of depression: inflammation, oxidative & nitrosative stress (IO&NS) and leaky gut as new targets for adjunctive treatments in depression Neuro Endocrinology Letters 29 3 2008 287 291
32. M. Maes "Functional" or "psychosomatic" symptoms, e.g. a flu-like malaise, aches and pain and fatigue, are major features of major and in particular of melancholic depression Neuro Endocrinology Letters 30 5 2009 564 573
33. M. Maes Depression is an inflammatory disease, but cell-mediated immune activation is the key component of depression Progress in Neuro- Psychopharmacology & Biological Psychiatry 35 3 2011 664 675
34. M. Maes, and H.Y. Meltzer The Serotonin Hypothesis of major depression. Selected Chapters on Mood Disorders. Psychopharmacology F. Bloom, D. Kupfer, The Fourth Generation of Progress 1995 Raven Press 933 944
35. M. Maes, E. Bosmans, E. Suy, C. Vandervorst, C. Dejonckheere, and J. Raus Antiphospholipid, antinuclear, Epstein-Barr and cytomegalovirus antibodies, and soluble interleukin-2 receptors in depressive patients Journal of Affective Disorders 21 2 1991 133 140
36. M. Maes, J. Lambrechts, E. Bosmans, J. Jacobs, E. Suy, C. Vandervorst, C. de Jonckheere, B. Minner, and J. Raus Evidence for a systemic immune activation during depression: results of leukocyte enumeration by flow cytometry in conjunction with monoclonal antibody staining Psychological Medicine 22 1 1992 45 53
37. M. Maes, W.J. Stevens, L.S. DeClerck, C.H. Bridts, D. Peeters, C. Schotte, and P. Cosyns A significantly increased number and percentage of B cells in depressed subjects: results of flow cytometric measurements Journal of Affective Disorders 24 3 1992 127 134
38. M. Maes, H. Meltzer, J. Jacobs, E. Suy, J. Calabrese, B. Minner, and J. Raus Autoimmunity in depression: increased antiphospholipid autoantibodies Acta Psychiatrica Scandinavica 87 3 1993 160 166
39. M. Maes, S. Scharpé, H.Y. Meltzer, G. Okayli, E. Bosmans, P. D'Hondt, B.V. Vanden Bossche, and P. Cosyns Increased neopterin and interferon-gamma secretion and lower availability of L-tryptophan in major depression: further evidence for an immune response Psychiatry Research 54 2 1994 143 160
40. M. Maes, I. Mihaylova, and J.C. Leunis Increased serum IgM antibodies directed against phosphatidyl inositol (Pi) in chronic fatigue syndrome (CFS) and major depression: evidence that an IgM-mediated immune response against Pi is one factor underpinning the comorbidity between both CFS and depression Neuro Endocrinology Letters 28 6 2007 861 867
41. M. Maes, I. Mihaylova, M. Kubera, and J.C. Leunis An IgM-mediated immune response directed against nitro-bovine serum albumin (nitro-BSA) in chronic fatigue syndrome (CFS) and major depression: evidence that nitrosative stress is another factor underpinning the comorbidity between major depression and CFS Neuro Endocrinology Letters 29 3 2008 313 319
42. M. Maes, R. Yirmyia, J. Noraberg, S. Brene, J. Hibbeln, G. Perini, M. Kubera, P. Bob, B. Lerer, and M. Maj The inflammatory & neurodegenerative (I&ND) hypothesis of depression: leads for future research and new drug developments in depression Metabolic Brain Disease 24 1 2009 27 53
43. M. Maes, P. Galecki, Y.S. Chang, and M. Berk A review on the oxidative and nitrosative stress (O&NS) pathways in major depression and their possible contribution to the (neuro)degenerative processes in that illness Progress in Neuro-Psychopharmacology & Biological Psychiatry 35 3 2011 676 692
44. M. Maes, B. Leonard, A. Fernandez, M. Kubera, G. Nowak, R. Veerhuis, A. Gardner, P. Ruckoanich, M. Geffard, C. Altamura, P. Galecki, and M. Berk (Neuro)inflammation and neuroprogression as new pathways and drug targets in depression: from antioxidants to kinase inhibitors Progress in Neuro-Psychopharmacology & Biological Psychiatry 35 3 2011 659 663
45. M. Maes, B.E. Leonard, A.M. Myint, M. Kubera, and R. Verkerk The new '5-HT' hypothesis of depression: cell-mediated immune activation induces indoleamine 2,3-dioxygenase, which leads to lower plasma tryptophan and an increased synthesis of detrimental tryptophan catabolites (TRYCATs), both of which contribute to the onset of depression Progress in Neuro-Psychopharmacology & Biological Psychiatry 35 3 2011 702 721
46. M. Maes, I. Mihaylova, M. Kubera, J.C. Leunis, and M. Geffard IgM-mediated autoimmune responses directed against multiple neoepitopes in depression: New pathways that underpin the inflammatory and neuroprogressive pathophysiology Journal of Affective Disorders 135 1-3 2011 414 418
47. C.J. March, B. Mosley, A. Larsen, D.P. Cerretti, G. Braedt, V. Price, S. Gillis, C.S. Henney, S.R. Kronheim, and K. Grabstein Cloning, sequence and expression of two distinct human interleukin-1 complementary DNAs Nature 315 6021 1985 641 647
48. W. Merens, L. Booij, P.J. Haffmans, and A. van der Does The effects of experimentally lowered serotonin function on emotional information processing and memory in remitted depressed patients Journal of Psychopharmacology 22 6 2008 653 662
49. S.F. Muakkassah-Kelly, J.W. Andresen, J.C. Shih, and P. Hochstein Decreased [3H]serotonin and [3H]spiperone binding consequent to lipid peroxidation in rat cortical membranes Biochemical and Biophysical Research Communications 104 3 1982 1003 1010
50. C. Murr, D. Fuchs, W. Gössler, A. Hausen, G. Reibnegger, E.R. Werner, G. Werner-Felmayer, H. Esterbauer, and H. Wachter Enhancement of hydrogen peroxide-induced luminol-dependent chemiluminescence by neopterin depends on the presence of iron chelator complexes FEBS Letters 338 2 1994 223 226
51. T.B. Ng, F. Liu, and L. Zhao Antioxidative and free radical scavenging activities of pineal indoles Journal of Neural Transmission 107 11 1999 1243 1251
52. A. Pierucci-Lagha, J. Covault, H.L. Bonkovsky, R. Feinn, C. Abreu, R.K. Sterling, R.J. Fontana, H.R. Kranzler HALT-C Trial Group A functional serotonin transporter gene polymorphism and depressive effects associated with interferon-alpha treatment Psychosomatics 51 2 2010 137 148
53. H. Plein, and M. Berk Changes in the platelet intracellular calcium response to serotonin in patients with major depression treated with electroconvulsive therapy: state or trait marker status International Clinical Psychopharmacology 15 2 2000 93 98
54. H. Plein, M. Berk, S. Eppel, and N. Butkow Augmented platelet calcium uptake in response to serotonin stimulation in patients with major depression measured using Mn2 + influx and 45Ca2 + uptake Life Sciences 66 5 2000 425 431
55. R.M. Post Kindling and sensitization as models for affective episode recurrence, cyclicity, and tolerance phenomena Neuroscience and Biobehavioral Reviews 31 6 2007 858 873
56. W. Schobersberger, G. Hoffmann, J. Grote, H. Wachter, and D. Fuchs Induction of inducible nitric oxide synthase expression by neopterin in vascular smooth muscle cells FEBS Letters 377 3 1995 461 464
57. W. Schobersberger, G. Hoffmann, P. Hobisch-Hagen, G. Bock, H. Volkl, G. Baier-Bitterlich, B. Wirleitner, H. Wachter, and D. Fuchs Neopterin and 7,8-dihydroneopterin induce apoptosis in the rat alveolar epithelial cell line L2 FEBS Letters 397 2-3 1996 263 268
58. A. Sluzewska, W. Samborski, M. Sobieska, R. Klein, E. Bosmans, and J.K. Rybakowski Serotonin antibodies in relation to immune activation in major depression Human Psychopharmacology 12 5 1996 453 458
59. C. Song, and H. Wang Cytokines mediated inflammation and decreased neurogenesis in animal models of depression Progress in Neuro-Psychopharmacology & Biological Psychiatry 35 3 2011 760 768
60. S. Su, J. Zhao, J.D. Bremner, A.H. Miller, W. Tang, M. Bouzyk, H. Snieder, O. Novik, N. Afzal, J. Goldberg, and V. Vaccarino Serotonin transporter gene, depressive symptoms, and interleukin-6 Circulation. Cardiovascular Genetics 2 6 2009 614 620
61. M.E. Thase, and A.J. Rush Treatment-resistant depression F.E. Bloom, D.J. Kupfer, Psychopharmacology, the Fourth Generation of Progress 1995 Raven Press New York NY 1081 1098
62. C.W. Tsao, Y.S. Lin, J.T. Cheng, C.F. Lin, H.T. Wu, S.R. Wu, and W.H. Tsai Interferon-alpha-induced serotonin uptake in Jurkat T cells via mitogen-activated protein kinase and transcriptional regulation of the serotonin transporter Journal of Psychopharmacology 22 7 2008 753 760
63. A.J. Van der Does The effects of tryptophan depletion on mood and psychiatric symptoms Journal of Affective Disorders 64 2-3 2001 107 119
64. G. Weiss, D. Fuchs, A. Hausen, G. Reibnegger, E.R. Werner, G. Werner-Felmayer, E. Semenitz, M.P. Dierich, and H. Wachter Neopterin modulates toxicity mediated by reactive oxygen and chloride species FEBS Letters 321 1 1993 89 92
65. M.Z. Wrona, and G. Dryhurst Interactions of 5-hydroxytryptamine with oxidative enzymes Biochemical Pharmacology 41 8 1991 1145 1162
66. R. Yirmiya, Y. Pollak, M. Morag, A. Reichenberg, O. Barak, R. Avitsur, Y. Shavit, H. Ovadia, J. Weidenfeld, A. Morag, M.E. Newman, and T. Pollmächer Illness, cytokines, and depression Annals of the New York Academy of Sciences 917 2000 478 487
67. O. Zachrisson, B. Regland, M. Jahreskog, M. Kron, and C.G. Gottfries A rating scale for fibromyalgia and chronic fatigue syndrome (the FibroFatigue scale) Journal of Psychosomatic Research 52 6 2002 501 509
68. C.B. Zhu, R.D. Blakely, and W.A. Hewlett The proinflammatory cytokines interleukin-1beta and tumor necrosis factor-alpha activate serotonin transporters Neuropsychopharmacology 31 10 2006 2121 2131
69. C.B. Zhu, K.M. Lindler, A.W. Owens, L.C. Daws, R.D. Blakely, and W.A. Hewlett Interleukin-1 receptor activation by systemic lipopolysaccharide induces behavioral despair linked to MAPK regulation of CNS serotonin transporters Neuropsychopharmacology 35 13 2010 2510 2520